Thanks to breakthrough engineering technologies and processes, Theraclion has developed the Echopulse® built from a unique technology of echotherapy combining focused ultrasound (HIFU) for therapy and real-tim ultrasound imaging for monitoring.
This double function allows a precise, individualized, non invasive and outpatient treatment of breast fibroadenomas and benign thyroid nodules.
In addition to its ergonomic design,the Echopulse includes an all-in-one system providing:
• millimetric accuracy during treatment
• a high-quality image
• performance of a step-by-step procedure through a touch screen monitor
• an easy to use device thanks to the mobile unit and its robotic arm
Echopulse® and its accessories are class IIB medical devices designed and marketed by Theraclion for the treatment of breast fibroadenomas and benign thyroid nodules. They are regulated health products which bear the CE marking as required by law. Please read the user guide carefully.